Related Experiment Video
Updated: Feb 10, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
Precision Medicine in Hormone Receptor-Positive Breast Cancer
Azadeh Nasrazadani1, Roby A Thomas1, Steffi Oesterreich2
1Department of Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
Abstract:
In recent decades, breast cancer has become largely manageable due to successes with hormone receptor targeting. Hormone receptor-positive tumors have favorable outcomes in comparison to estrogen receptor (ESR1, ER)/progesterone receptor-negative tumors given the targetable nature of these tumors, as well as their inherently less aggressive character. Nonetheless, treatment resistance is frequently encountered due to a variety of mechanisms, including ESR1 mutations and loss of ER expression. A new era of precision medicine utilizes a range of methodologies to allow real-time analysis of individual genomic signatures in metastases and liquid biopsies with the goal of finding clinically actionable targets. Preliminary studies have shown improved progression-free survival and overall survival with implementation of this information for clinical decision making. In this review, we will discuss the opportunities and challenges in integrating precision medicine through next-generation genomic sequencing into the management of breast cancer.
Insights
Precision medicine advances breast cancer treatment by analyzing genomic signatures in metastases and liquid biopsies. This approach aims to overcome treatment resistance in hormone receptor-positive breast cancer, improving patient survival outcomes.
Area of Science:
- Oncology
- Genomics
- Precision Medicine
Background:
- Hormone receptor-positive breast cancer is largely manageable with targeted therapies.
- Treatment resistance, often due to ESR1 mutations or ER loss, remains a significant challenge.
- Estrogen receptor (ER) and progesterone receptor (PR) status are key prognostic and predictive markers.
Purpose of the Study:
- To review the integration of precision medicine, specifically next-generation genomic sequencing (NGS), into breast cancer management.
- To discuss the opportunities and challenges associated with utilizing genomic data for clinical decision-making.
- To highlight the potential of real-time genomic analysis in overcoming treatment resistance.
Main Methods:
- Review of current literature on precision medicine in breast cancer.
- Analysis of methodologies for real-time genomic signature analysis in metastases and liquid biopsies.
- Discussion of the role of next-generation genomic sequencing (NGS).
Main Results:
- Precision medicine enables real-time analysis of individual genomic signatures.
- Genomic profiling of metastases and liquid biopsies can identify actionable targets.
- Preliminary studies suggest improved progression-free and overall survival with precision medicine implementation.
Conclusions:
- Integrating precision medicine through NGS offers new strategies for managing breast cancer.
- Addressing treatment resistance mechanisms like ESR1 mutations is crucial.
- Real-time genomic analysis holds promise for personalized breast cancer treatment and improved patient outcomes.
Related Concept Videos
Intracellular Hormone Receptors
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Hormonal Regulation
Hormonal Regulation
Plant Hormones

